User profiles for Gail Matthews
 | Gail MatthewsKirby Institute, University of New South Wales Verified email at kirby.unsw.edu.au Cited by 13054 |
[HTML][HTML] Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection develop
post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here, we …
post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here, we …
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
GL Dean, SG Edwards, NJ Ives, G Matthews, EF Fox… - Aids, 2002 - journals.lww.com
Treatment of tuberculosis in HIV-infected persons in the era... : AIDS Treatment of tuberculosis
in HIV-infected persons in the era of highly active antiretroviral therapy : AIDS Log in or Register …
in HIV-infected persons in the era of highly active antiretroviral therapy : AIDS Log in or Register …
Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men
…, ML Chaix, M Fisher, H Gőtz, GV Matthews… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Since 2000, there has been a marked rise in acute hepatitis C
virus (HCV) in human immunodeficiency virus (HIV)-positive men who have sex with men (MSM). …
virus (HCV) in human immunodeficiency virus (HIV)-positive men who have sex with men (MSM). …
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non …
…, J Lalezari, J Mallolas, M Bloch, GV Matthews… - The lancet HIV, 2015 - thelancet.com
Background Hepatitis C virus (HCV) infection is a leading cause of morbidity and mortality
in patients with HIV-1. The C-EDGE CO-INFECTION study assessed the efficacy, safety, and …
in patients with HIV-1. The C-EDGE CO-INFECTION study assessed the efficacy, safety, and …
A global scientific strategy to cure hepatitis B
Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same
scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) …
scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) …
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
TJ Van De Laar, GV Matthews, M Prins, M Danta - Aids, 2010 - journals.lww.com
Since 2000 outbreaks of acute hepatitis C virus (HCV) among HIV-positive men who have
sex with men (MSM) who denied injecting drug use have been reported from Europe, the …
sex with men (MSM) who denied injecting drug use have been reported from Europe, the …
Reactions to suffering of others under conditions of indirect responsibility.
MJ Lerner, G Matthews - Journal of Personality and social …, 1967 - psycnet.apa.org
PRESENTED AS A STUDY OF PAIRED-ASSOCIATE LEARNING TO 66 FEMALE
UNDERGRADUATES WHO PARTICIPATED IN PAIRS. EACH S, WITH THE EXCEPTION OF THOSE …
UNDERGRADUATES WHO PARTICIPATED IN PAIRS. EACH S, WITH THE EXCEPTION OF THOSE …
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
…, M Lacalamita, A Dunlop, GV Matthews… - The lancet …, 2018 - thelancet.com
Background Despite revised guidelines that no longer exclude people who inject drugs (PWID)
from treatment for hepatitis C virus (HCV) infection, many clinicians are reluctant to treat …
from treatment for hepatitis C virus (HCV) infection, many clinicians are reluctant to treat …
[HTML][HTML] SARS-CoV-2 Omicron BA. 5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral …
Background Genetically distinct viral variants of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) have been recorded since January 2020. The introduction of global …
2 (SARS-CoV-2) have been recorded since January 2020. The introduction of global …
[PDF][PDF] Potential role for Interleukin‐28B genotype in treatment decision‐making in recent hepatitis C virus infection
…, K Petoumenos, M Hellard, GV Matthews… - …, 2010 - Wiley Online Library
Polymorphisms in the IL28B (interleukin‐28B) gene region are important in predicting outcome
following therapy for chronic hepatitis C virus (HCV) infection. We evaluated the role of …
following therapy for chronic hepatitis C virus (HCV) infection. We evaluated the role of …